Synergistic effect of prostaglandin F2alpha and cyclic AMP on glucose transport in 3T3-L1 adipocytes.
The combined effect of prostaglandin F2alpha (PGF2alpha) and cAMP on glucose transport in 3T3-L1 adipocytes was examined. In cells pretreated with PGF2alpha and 8-bromo cAMP for 8 h, a synergy between these two agents on glucose uptake was found. Insulin-stimulated glucose transport, on the other hand, was only slightly affected. The synergistic effect of these two agents was suppressed in the presence of cycloheximide and actinomycin D. In concord, immunoblot and Northern blot analyses revealed that GLUT1 protein and mRNA levels were both increased in cells pretreated with both PGF2alpha and 8-bromo cAMP, greater than the additive effect of each agent alone. The synergistic action of PGF2alpha with 8-bromo cAMP to enhance glucose transport was inhibited by GF109203X, a selective protein kinase C (PKC) inhibitor. In addition, in cells depleted of diacylglycerol-sensitive PKC by prolonged treatment with 4beta-phorbol 12beta-myristate 13alpha-acetate, a PKC activator, the synergistic effects of PGF2alpha and 8-bromo cAMP on glucose transport and GLUT1 mRNA accumulation were both abolished. Taken together, these results indicate that PGF2alpha may act with cAMP in a synergistic way to increase glucose transport, probably through enhanced GLUT1 expression by a PKC-dependent mechanism.
Chiou
Guang-Yuh
GY
Institute of Biochemistry, National Yang-Ming University, Taipei, Taiwan, Republic of China.
Fong
Jim C
JC
D041721:3T3-L1 Cells; D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology*; D017667:Adipocytes / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D000818:Animals; D001483:Base Sequence; D017931:DNA Primers; D015237:Dinoprost / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D051379:Mice; D011493:Protein Kinase C / Q000378:metabolism
D017931:DNA Primers; D015124:8-Bromo Cyclic Adenosine Monophosphate; D015237:Dinoprost; D011493:Protein Kinase C; D005947:Glucose